Abstract
Findings Do Not Support Routine CYP2D6 Genotyping in Gauging Tamoxifen Effectiveness in Preventing Breast Cancer Recurrence
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1097/01.cot.0000396093.73931.cc
Journal: Oncology Times | Publication Date: Mar 1, 2011 |
Findings Do Not Support Routine CYP2D6 Genotyping in Gauging Tamoxifen Effectiveness in Preventing Breast Cancer Recurrence
Join us for a 30 min session where you can share your feedback and ask us any queries you have